Skip to content Skip to footer

Loading Results

Pharma and Life Sciences industry: Tax spotlight

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.

September 16, 2020

To see all Tap into Tax and PwC Tax podcasts, visit us here. You can also subscribe and listen to all episodes at your convenience via your desktop computer or smart device at Apple Podcasts, Stitcher, Google Play, and Overcast.

In this episode, we speak with Michelle Lee, PwC's US Pharmaceutical and Life Sciences Tax Leader, to discuss the business and tax issues in one of the most high-profile industries during the pandemic, pharmaceuticals and life sciences (including medical devices). We will cover the general state of the industry, operational impacts due to supply chain disruption, the impact of US election and global reform as well as the influence of technology on audit and reputational risk. Featuring:

Contact us

Jonathan Swerling

US Tax Marketing Leader, PwC US

Follow us